FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38340311000001100: Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1318041000001116 Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1318051000001118 Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Gestodene 75microgram / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has AMP Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Gestodene true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start